Logo image of IRIX

IRIDEX CORP (IRIX) Stock Price, Quote, News and Overview

NASDAQ:IRIX - Nasdaq - US4626841013 - Common Stock - Currency: USD

1.03  +0.01 (+0.98%)

IRIX Quote, Performance and Key Statistics

IRIDEX CORP

NASDAQ:IRIX (4/21/2025, 8:23:00 PM)

1.03

+0.01 (+0.98%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High3.25
52 Week Low0.78
Market Cap17.29M
Shares16.79M
Float13.35M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)05-08 2025-05-08/amc
IPO02-16 1996-02-16


IRIX short term performance overview.The bars show the price performance of IRIX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 -20 -30

IRIX long term performance overview.The bars show the price performance of IRIX in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of IRIX is 1.03 USD. In the past month the price increased by 4.04%. In the past year, price decreased by -64.11%.

IRIDEX CORP / IRIX Daily stock chart

IRIX Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.17 225.27B
ISRG INTUITIVE SURGICAL INC 63.89 167.79B
BSX BOSTON SCIENTIFIC CORP 37.28 138.41B
SYK STRYKER CORP 27.86 129.62B
MDT MEDTRONIC PLC 15.32 104.91B
BDX BECTON DICKINSON AND CO 14.13 56.45B
EW EDWARDS LIFESCIENCES CORP 26.41 40.68B
IDXX IDEXX LABORATORIES INC 36.15 32.95B
RMD RESMED INC 23.85 30.97B
GEHC GE HEALTHCARE TECHNOLOGY 13.47 27.69B
DXCM DEXCOM INC 40.07 25.92B
PHG KONINKLIJKE PHILIPS NVR- NY 14.83 21.89B

About IRIX

Company Profile

IRIX logo image IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. The company is headquartered in Mountain View, California and currently employs 111 full-time employees. The company develops and commercializes products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probes products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.

Company Info

IRIDEX CORP

1212 Terra Bella Ave

Mountain View CALIFORNIA 94043 US

CEO: David I. Bruce

Employees: 111

Company Website: https://www.iridex.com/

Investor Relations: http://phx.corporate-ir.net/phoenix.zhtml?c=112360&p=irol-irhome

Phone: 16509404700

IRIDEX CORP / IRIX FAQ

What is the stock price of IRIDEX CORP today?

The current stock price of IRIX is 1.03 USD. The price increased by 0.98% in the last trading session.


What is the ticker symbol for IRIDEX CORP stock?

The exchange symbol of IRIDEX CORP is IRIX and it is listed on the Nasdaq exchange.


On which exchange is IRIX stock listed?

IRIX stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for IRIDEX CORP stock?

6 analysts have analysed IRIX and the average price target is 2.04 USD. This implies a price increase of 98.06% is expected in the next year compared to the current price of 1.03. Check the IRIDEX CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is IRIDEX CORP worth?

IRIDEX CORP (IRIX) has a market capitalization of 17.29M USD. This makes IRIX a Nano Cap stock.


How many employees does IRIDEX CORP have?

IRIDEX CORP (IRIX) currently has 111 employees.


What are the support and resistance levels for IRIDEX CORP (IRIX) stock?

IRIDEX CORP (IRIX) has a support level at 0.96 and a resistance level at 1.04. Check the full technical report for a detailed analysis of IRIX support and resistance levels.


Is IRIDEX CORP (IRIX) expected to grow?

The Revenue of IRIDEX CORP (IRIX) is expected to grow by 5.44% in the next year. Check the estimates tab for more information on the IRIX EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy IRIDEX CORP (IRIX) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does IRIDEX CORP (IRIX) stock pay dividends?

IRIX does not pay a dividend.


When does IRIDEX CORP (IRIX) report earnings?

IRIDEX CORP (IRIX) will report earnings on 2025-05-08, after the market close.


What is the Price/Earnings (PE) ratio of IRIDEX CORP (IRIX)?

IRIDEX CORP (IRIX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.54).


What is the Short Interest ratio of IRIDEX CORP (IRIX) stock?

The outstanding short interest for IRIDEX CORP (IRIX) is 2.02% of its float. Check the ownership tab for more information on the IRIX short interest.


IRIX Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to IRIX. When comparing the yearly performance of all stocks, IRIX is a bad performer in the overall market: 91.83% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

IRIX Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to IRIX. IRIX has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IRIX Financial Highlights

Over the last trailing twelve months IRIX reported a non-GAAP Earnings per Share(EPS) of -0.54. The EPS increased by 8.47% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -30.58%
ROE -424.89%
Debt/Equity 0.48
Chartmill High Growth Momentum
EPS Q2Q%72.22%
Sales Q2Q%1.94%
EPS 1Y (TTM)8.47%
Revenue 1Y (TTM)-6.19%

IRIX Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 43% to IRIX. The Buy consensus is the average rating of analysts ratings from 6 analysts.

For the next year, analysts expect an EPS growth of 49% and a revenue growth 5.44% for IRIX


Ownership
Inst Owners19.45%
Ins Owners3.68%
Short Float %2.02%
Short Ratio5.64
Analysts
Analysts43.33
Price Target2.04 (98.06%)
EPS Next Y49%
Revenue Next Year5.44%